Anti-IL-23 preferentially inhibits pathogenic TH17 cells

被引：0
|
作者：
Ranzinger, D. [1 ]
Thomas, J. [3 ]
Pilz, A. C. [1 ]
Seiringer, P. [2 ]
Eyerich, S. [2 ]
Eyerich, K. [1 ]
机构：
[1] Albert Ludwigs Univ Freiburg, Dermatology, Freiburg, Germany
[2] Tech Univ Munich, Dermatol, Munich, Germany
[3] Karolinska Inst, Stockholm, Sweden
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
045
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [41] TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic?
    Marwaha, Ashish K.
    Leung, Nicole J.
    McMurchy, Alicia N.
    Levings, Megan K.
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [42] Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
    Haugh, Isabel M.
    Preston, Allie K.
    Kivelevitch, Dario N.
    Menter, Alan M.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3879 - 3883
  • [43] RISANKIZUMAB, BUT NOT USTEKINUMAB OR VEDOLIZUMAB, DOWNREGULATES IL-23-INDUCED MUCOSAL PATHOGENIC TH17 CELLS IN PATIENTS WITH CROHN'S DISEASE
    Noviello, Daniele
    Dusetti, Irene
    Pivorunas, Valerie L.
    Conforti, Francesco Simone
    Amoroso, Chiara
    Ciafardini, Clorinda
    Lovati, Ambra E.
    Vecchi, Maurizio
    Facciotti, Federica
    Paroni, Moira
    Caprioli, Flavio
    GASTROENTEROLOGY, 2024, 166 (05) : S792 - S792
  • [44] Anti-IL-23 antibodies against prostate cancer?
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2019, 139 (02) : 143 - 143
  • [45] Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn's disease
    Noviello, D.
    Dusetti, I.
    Pivorunas, V.
    Lovati, A. E.
    Ciafardini, C.
    Amoroso, C.
    Conforti, F.
    Sed, N. Piazza O.
    Vecchi, M.
    Facciotti, F.
    Paroni, M.
    Caprioli, F.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1769 - I1770
  • [46] Th17 Cells and IL-17A in Ischemic Stroke
    Wang, Jingjing
    Gao, Yuxiao
    Yuan, Yujia
    Wang, Huan
    Wang, Zhao
    Zhang, Xiangjian
    MOLECULAR NEUROBIOLOGY, 2024, 61 (04) : 2411 - 2429
  • [47] IL-10 producing non-pathogenic Th17 cells and their role in EAE
    Wolbert, J.
    Hartlehnert, M.
    Schafflick, D.
    Wiendl, H.
    zu Hoerste, G. Meyer
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 394 - 394
  • [48] Pathogenic role of interleukin (IL)-26 producing Th17 cells in the acute forms of psoriasis
    Fries, A.
    Di Domizio, J.
    Demaria, O.
    Triboulet, C.
    Gilliet, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S17 - S17
  • [49] Th17 Cells and IL-17A in Ischemic Stroke
    Jingjing Wang
    Yuxiao Gao
    Yujia Yuan
    Huan Wang
    Zhao Wang
    Xiangjian Zhang
    Molecular Neurobiology, 2024, 61 : 2411 - 2429
  • [50] Clinical Significance of IL-23 Regulating IL-17A and/or IL-17F Positive Th17 Cells in Chronic Periodontitis
    Luo, Zhenhua
    Wang, Hui
    Wu, Yunlong
    Sun, Zheng
    Wu, Yafei
    MEDIATORS OF INFLAMMATION, 2014, 2014
12345